| KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors DS Hong, MG Fakih, JH Strickler, J Desai, GA Durm, GI Shapiro, ... New England Journal of Medicine 383 (13), 1207-1217, 2020 | 1395 | 2020 |
| Sotorasib for Lung Cancers with KRAS p.G12C Mutation F Skoulidis, BT Li, GK Dy, TJ Price, GS Falchook, J Wolf, A Italiano, ... New England Journal of Medicine 384 (25), 2371-2381, 2021 | 1244 | 2021 |
| Prospective validation of rapid plasma genotyping for the detection of EGFR and KRAS mutations in advanced lung cancer AG Sacher, C Paweletz, SE Dahlberg, RS Alden, A O’Connell, N Feeney, ... JAMA oncology 2 (8), 1014-1022, 2016 | 612 | 2016 |
| Bias-corrected targeted next-generation sequencing for rapid, multiplexed detection of actionable alterations in cell-free DNA from advanced lung cancer patients CP Paweletz, AG Sacher, CK Raymond, RS Alden, A O'Connell, SL Mach, ... Clinical Cancer Research 22 (4), 915-922, 2016 | 310 | 2016 |
| Biomarkers for the clinical use of PD-1/PD-L1 inhibitors in non–small-cell lung cancer: a review AG Sacher, L Gandhi JAMA oncology 2 (9), 1217-1222, 2016 | 294 | 2016 |
| PD‐L1 expression in non‐small cell lung carcinoma: comparison among cytology, small biopsy, and surgical resection specimens JJ Heymann, WA Bulman, D Swinarski, CA Pagan, JP Crapanzano, ... Cancer cytopathology 125 (12), 896-907, 2017 | 215 | 2017 |
| Association between younger age and targetable genomic alterations and prognosis in non–small-cell lung cancer AG Sacher, SE Dahlberg, J Heng, S Mach, PA Jänne, GR Oxnard JAMA oncology 2 (3), 313-320, 2016 | 215 | 2016 |
| Chemical genetics reveals a complex functional ground state of neural stem cells P Diamandis, J Wildenhain, ID Clarke, AG Sacher, J Graham, DS Bellows, ... Nature chemical biology 3 (5), 268-273, 2007 | 180 | 2007 |
| Identification of a bone marrow–derived epithelial-like population capable of repopulating injured mouse airway epithelium AP Wong, A Keating, WY Lu, P Duchesneau, X Wang, A Sacher, J Hu, ... The Journal of clinical investigation 119 (2), 336-348, 2009 | 164 | 2009 |
| Acquired METD1228V Mutation and Resistance to MET Inhibition in Lung Cancer M Bahcall, T Sim, CP Paweletz, JD Patel, RS Alden, Y Kuang, AG Sacher, ... Cancer discovery 6 (12), 1334-1341, 2016 | 152 | 2016 |
| Targeted cell replacement with bone marrow cells for airway epithelial regeneration AP Wong, AE Dutly, A Sacher, H Lee, DM Hwang, M Liu, S Keshavjee, ... American journal of physiology-lung cellular and molecular physiology 293 (3 …, 2007 | 120 | 2007 |
| Elderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC? AG Sacher, LW Le, NB Leighl, LE Coate Journal of Thoracic Oncology 8 (3), 366-368, 2013 | 102 | 2013 |
| Application of plasma genotyping technologies in non–small cell lung cancer: a practical review AG Sacher, KM Komatsubara, GR Oxnard Journal of Thoracic Oncology 12 (9), 1344-1356, 2017 | 97 | 2017 |
| Real‐world chemotherapy treatment patterns in metastatic non–small cell lung cancer: are patients undertreated? AG Sacher, LW Le, A Lau, CC Earle, NB Leighl Cancer 121 (15), 2562-2569, 2015 | 88 | 2015 |
| Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation A Sacher, P LoRusso, MR Patel, WH Miller Jr, E Garralda, MD Forster, ... New England Journal of Medicine 389 (8), 710-721, 2023 | 85 | 2023 |
| LBA61 First analysis of RAIN-701: Study of tarloxotinib in patients with non-small cell lung cancer (NSCLC) EGFR Exon 20 insertion, HER2-activating mutations & other solid … SV Liu, LC Villaruz, VHF Lee, VW Zhu, CS Baik, A Sacher, CE McCoach, ... Annals of Oncology 31, S1189, 2020 | 75 | 2020 |
| Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancer LE Coate, C Massey, A Hope, A Sacher, K Barrett, A Pierre, N Leighl, ... Journal of Thoracic Oncology 6 (3), 537-544, 2011 | 69 | 2011 |
| Talimogene laherparepvec (T-Vec) for the treatment of melanoma and other cancers C Grigg, Z Blake, R Gartrell, A Sacher, B Taback, Y Saenger Seminars in oncology 43 (6), 638-646, 2016 | 67 | 2016 |
| Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year … GK Dy, R Govindan, V Velcheti, GS Falchook, A Italiano, J Wolf, ... Journal of Clinical Oncology 41 (18), 3311-3317, 2023 | 66 | 2023 |
| Durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real … A Desilets, F Blanc-Durand, S Lau, T Hakozaki, R Kitadai, J Malo, ... European Journal of Cancer 142, 83-91, 2021 | 61 | 2021 |